You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 7,728,143

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,728,143

Title:	Salt and crystalline forms thereof of a drug
Abstract:	A crystalline form of a drug, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
Inventor(s):	Zhang; Geoff G. Z. (Libertyville, IL), Bradley; Michael F. (Covington, WA), Barnes; David M. (Lake Villa, IL), Henry; Rodger (Wildwood, IL)
Assignee:	Abbott Laboratories (Abbott Park, IL)
Application Number:	11/245,561
Patent Claims:	1. D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate trihydrate salt. 2. Crystalline D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate salt characterized, when measured at about 25.degree. C. with Cu--K.alpha. radiation, by the powder diffraction pattern shown in FIG. 1. 3. Crystalline D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate trihydrate salt characterized, when measured at about 25.degree. C. with Cu--K.alpha. radiation, by the powder diffraction pattern shown in FIG. 2. 4. A process for making D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate salt comprising dehydrating D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate trihydrate salt. 5. D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate salt prepared as described in claim 4. 6. A process for making D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate trihydrate salt by crystallization of D-glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoro-pyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-- hydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate salt from water, with or without an alcohol. 7. D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-h- ydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylate trihydrate salt prepared as described in claim 6.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.